Addie Diane, Belák Sándor, Boucraut-Baralon Corine, Egberink Herman, Frymus Tadeusz, Gruffydd-Jones Tim, Hartmann Katrin, Hosie Margaret J, Lloret Albert, Lutz Hans, Marsilio Fulvio, Pennisi Maria Grazia, Radford Alan D, Thiry Etienne, Truyen Uwe, Horzinek Marian C
European Advisory Board on Cat Diseases (ABCD).
J Feline Med Surg. 2009 Jul;11(7):594-604. doi: 10.1016/j.jfms.2009.05.008.
Feline coronavirus infection is ubiquitous in domestic cats, and is particularly common where conditions are crowded. While most FCoV-infected cats are healthy or display only a mild enteritis, some go on to develop feline infectious peritonitis, a disease that is especially common in young cats and multi-cat environments. Up to 12% of FCoV-infected cats may succumb to FIP, with stress predisposing to the development of disease.
The 'wet' or effusive form, characterised by polyserositis (abdominal and/or thoracic effusion) and vasculitis, and the 'dry' or non-effusive form (pyogranulomatous lesions in organs) reflect clinical extremes of a continuum. The clinical picture of FIP is highly variable, depending on the distribution of the vasculitis and pyogranulomatous lesions. Fever refractory to antibiotics, lethargy, anorexia and weight loss are common non-specific signs. Ascites is the most obvious manifestation of the effusive form.
The aetiological diagnosis of FIP ante-mortem may be difficult, if not impossible. The background of the cat, its history, the clinical signs, laboratory changes, antibody titres and effusion analysis should all be used to help in decision-making about further diagnostic procedures. At the time of writing, there is no non-invasive confirmatory test available for cats without effusion.
In most cases FIP is fatal. Supportive treatment is aimed at suppressing the inflammatory and detrimental immune response. However, there are no controlled studies to prove any beneficial effect of corticosteroids.
At present, only one (intranasal) FIP vaccine is available, which is considered as being non-core. Kittens may profit from vaccination when they have not been exposed to FCoV (eg, in an early-weaning programme), particularly if they enter a FCoV-endemic environment.
猫冠状病毒感染在家猫中普遍存在,在饲养环境拥挤的地方尤为常见。虽然大多数感染猫冠状病毒的猫很健康或仅表现出轻度肠炎,但有些猫会发展为猫传染性腹膜炎,这种疾病在幼猫和多猫环境中尤为常见。高达12%感染猫冠状病毒的猫可能死于猫传染性腹膜炎,应激会促使疾病的发展。
“湿性”或渗出性形式,其特征为多浆膜炎(腹腔和/或胸腔积液)和血管炎,以及“干性”或非渗出性形式(器官中的脓性肉芽肿病变)反映了一个连续过程的临床极端情况。猫传染性腹膜炎的临床症状高度可变,取决于血管炎和脓性肉芽肿病变的分布。对抗生素治疗无效的发热、嗜睡、厌食和体重减轻是常见的非特异性症状。腹水是渗出性形式最明显的表现。
生前对猫传染性腹膜炎进行病因诊断可能很困难,甚至不可能。猫的背景、病史、临床症状、实验室变化、抗体滴度和积液分析都应用于辅助决定进一步的诊断程序。在撰写本文时,对于没有积液的猫没有可用的非侵入性确诊测试。
在大多数情况下,猫传染性腹膜炎是致命的。支持性治疗旨在抑制炎症和有害的免疫反应。然而,没有对照研究证明皮质类固醇有任何有益效果。
目前,只有一种(鼻内)猫传染性腹膜炎疫苗可用,该疫苗被认为是非核心疫苗。小猫在未接触猫冠状病毒(例如,在早期断奶计划中)时接种疫苗可能有益,特别是如果它们进入猫冠状病毒流行的环境。